Skip to main content
    L

    Labcorp Holdings Inc. (LH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $368.27
    -4.19 (-1.13%)

    Market Cap: $30.08B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Labcorp Holdings Inc. (LH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Labcorp Holdings (LH) has a market cap of $30.08B and an enterprise value of $35.67B. Its trailing P/E of 20.4x is above its 10-year median of 15.3x. Its share count is down 2.05% from a year earlier.

    Total Valuation

    Enterprise value is 18.58% above the market cap, as debt exceeds cash.

    Market Cap$30.08B
    Enterprise Value$35.67B
    Latest price (Nov 17, 2026)$368.27

    Key Dates

    The next earnings report is expected on Feb 15, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 24, 2026.

    Next Earnings DateFeb 15, 2027 (expected)
    Last Earnings DateOct 28, 2026
    Next Ex-Dividend DateNov 24, 2026
    Next Payment DateDec 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.12% in the quarter ended Sep 30, 2026 and shrank 1.47% a year over 2 years.

    Shares Outstanding81.20M
    Shares Change (YoY)-2.05%
    Shares Change (QoQ)+0.12%
    Share Count Growth (2Y CAGR)-1.47%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 3.4x. Its year-end P/E ranged from 8.5x to 16.6x from 2016 to 2025.

    P/E Ratio20.4x
    Forward P/E19.3x
    P/S Ratio2.0x
    Forward P/S2.0x
    P/B Ratio3.4x
    P/FCF Ratio23.2x
    P/OCF Ratio16.6x
    PEG Ratio3.3

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 17.6x EBITDA and 27.6x free cash flow.

    EV / Earnings35.5x
    EV / Sales2.4x
    EV / EBITDA17.6x
    EV / EBIT24.4x
    EV / FCF27.6x

    Price Statistics

    The stock is up 38.70% over 52 weeks and trades 11.12% above its 50-day average.

    Beta (1Y)0.34
    52-Week Change+38.70%
    1-Month Change+15.51%
    3-Month Change+11.69%
    6-Month Change+45.88%
    5-Year Change+25.91%
    10-Year Change+188.33%
    Total Return (1Y)+39.79%
    Total Return (3Y CAGR)+21.12%
    Total Return (5Y CAGR)+9.27%
    Return vs SPY (1Y)+30.92%
    Max Drawdown (1Y)-13.59%
    Max Drawdown (3Y)-17.36%
    Sharpe Ratio (1Y)1.49
    Correlation with SPY (1Y)0.20
    50-Day Average$331.42
    200-Day Average$292.75
    52-Week Range$243.20 to $375.10
    RSI (14 Days)65.4
    Average Volume (20 Days)780.92K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.41x current liabilities, and total debt is 0.66x shareholder equity.

    Current Ratio1.41x
    Quick Ratio1.22x
    Debt / Equity0.66x
    Debt / EBITDA2.90x
    Debt / FCF4.55x
    Interest Coverage6.34x

    Returns and Efficiency

    Return on invested capital is 8.16% over the last 12 months, against a 5-year average of 7.93%.

    Return on Equity (ROE)11.36%
    Return on Assets (ROA)5.31%
    Return on Invested Capital (ROIC)8.16%
    Return on Capital Employed (ROCE)9.07%
    ROE (5Y Average)12.13%
    ROA (5Y Average)5.87%
    ROIC (5Y Average)7.93%
    Asset Turnover0.78x
    Inventory Turnover18.84x
    Receivables Turnover5.76x
    Cash Conversion Cycle58 days

    Taxes

    Income tax took 17.93% of pretax income over the last 12 months.

    Income Tax (TTM)$219.60M
    Effective Tax Rate17.93%

    Scores

    LH has an Altman Z-Score of 3.54, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score3.54
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $14.59B over the last 12 months is up 6.02% from the 12 months before.

    Revenue$14.59B
    Revenue Growth (YoY)+6.02%
    Gross Profit$4.23B
    Operating Income$1.50B
    Pretax Income$1.22B
    Net Income$1.01B
    EBITDA$2.02B
    EBIT$1.46B
    Reported EPS (TTM)$18.09

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 46.78% of the $18.92B in total assets.

    Cash and Equivalents$261.80M
    Total Debt$5.85B
    Net Debt$5.59B
    Net Debt Per Share$68.84
    Working Capital$1.15B
    Shareholder Equity$8.85B
    Book Value Per Share$108.96
    Tangible Book Value-$2.05B
    Total Assets$18.92B
    Total Liabilities$10.06B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $528.10M of capital spending, operating cash flow left $1.29B of free cash flow.

    Operating Cash Flow$1.81B
    Capital Expenditures$528.10M
    Free Cash Flow$1.29B
    FCF Per Share$15.85
    Depreciation and Amortization$559.20M
    Dividends Paid$237.40M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 10.29%, against a 5-year average of 11.91%.

    Gross Margin28.96%
    Operating Margin10.29%
    Pretax Margin8.39%
    Net Margin6.89%
    EBITDA Margin13.84%
    EBIT Margin10.01%
    FCF Margin8.82%
    Gross Margin (5Y Average)30.71%
    Operating Margin (5Y Average)11.91%
    Net Margin (5Y Average)8.88%

    Growth

    Revenue grew 5.55% a year over 3 years, and EPS fell 6.15% a year.

    Revenue Growth (3Y CAGR)+5.55%
    Revenue Growth (5Y CAGR)-0.04%
    EPS Growth (3Y CAGR)-6.15%
    EPS Growth (5Y CAGR)-7.22%
    FCF Growth (3Y CAGR)-7.56%
    FCF Growth (5Y CAGR)-7.21%
    Operating Income Growth (3Y CAGR)-1.22%
    Book Value Per Share Growth (2Y CAGR)+5.69%

    Revenue and profit by year

    Dividends and Yields

    LH pays out 12.88% of earnings as dividends.

    Dividend Per Share (Annual)$2.88
    Dividend Yield0.78%
    Payment ScheduleQuarterly
    Payout Ratio12.88%
    FCF Payout Ratio18.45%
    Earnings Yield4.90%
    FCF Yield4.30%
    Buyback Yield1.98%
    Shareholder Yield2.78%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on May 13, 2002.

    Last Split DateMay 13, 2002
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 11 similar companies, LH has the lowest P/E and the 7th highest ROIC.

    P/E Ratio20.4x vs 31.3x median
    P/S Ratio2.0x vs 6.5x median
    ROIC8.16% vs 8.47% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.02% vs +8.73% median
    Dividend Yield0.78% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.83% and EPS growth at 9.19% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.83%
    EPS Growth Forecast (2Y CAGR)+9.19%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LH

    What is LH's market cap?

    Labcorp Holdings has a market cap of $30.08B. Its enterprise value, which adds debt and subtracts cash, is $35.67B.

    What is LH's P/E ratio?

    Labcorp Holdings has a trailing P/E ratio of 20.4x and a forward P/E of 19.3x.

    How many shares of LH are outstanding?

    Labcorp Holdings has 81.20M shares outstanding. The count is down 2.05% from a year earlier.

    Does LH pay a dividend?

    Yes. Labcorp Holdings pays $2.88 a share a year, a dividend yield of 0.78%.

    How much debt does LH have?

    Labcorp Holdings has $5.85B of total debt and $261.80M of cash and equivalents, a net debt position of $5.59B.